已入深夜,您辛苦了!由于当前在线用户较少,发布求助请尽量完整地填写文献信息,科研通机器人24小时在线,伴您度过漫漫科研夜!祝你早点完成任务,早点休息,好梦!

Corporate venture capital, disclosure, and financial reporting

审查 商誉 业务 会计 企业风险投资 样品(材料) 风险投资 资产(计算机安全) 投资(军事) 自愿披露 财务 化学 法学 计算机安全 色谱法 计算机科学 政治 政治学
作者
Sophia Hamm,Michael J. Jung,Min Park
出处
期刊:Corporate Governance: An International Review [Wiley]
卷期号:29 (6): 541-566 被引量:7
标识
DOI:10.1111/corg.12379
摘要

Abstract Research Question/Issue Corporate venture capital (CVC) is one of the most important avenues for corporate innovation today, yet there can be unintended consequences related to anticompetitive practices. Recent scrutiny from regulators and policymakers underscores their growing desire for more information about firms' CVC investment activities, even of those previously believed to be too small to matter. Research Findings/Insights Using a comprehensive sample of 115 publicly listed US parent firms that owned 133 CVC firms, we document that for almost half of the firm‐years in our sample, parent firms do not disclose any information about their CVC program. Among the parent firms that do disclose their CVC activities, we find that they disclose less when they make investments in industries outside of their core industry. Firms with a CVC program, relative to similar firms without a CVC program, tend to make more future acquisitions and report less future goodwill asset write‐downs. Theoretical/Academic Implications Variation in details of CVC disclosures explained by within‐industry versus outside‐industry investments is consistent with theories on voluntary/discretionary disclosure. Future research can examine other characteristics of CVC investments that explain how parent firms report their CVC activities. Practitioner/Policy Implications This study documents the current state of affairs with respect to the amount of publicly available CVC information for a large sample of firms, an important starting point for regulators and policymakers to conduct an informed debate about whether disclosure requirements should be expanded. Our focus on investment disclosures can apply to other settings in which the investing public could benefit from greater transparency, such as Special Purpose Acquisition Companies (SPACs).
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
janice116688发布了新的文献求助20
2秒前
一澡干菜发布了新的文献求助30
5秒前
6秒前
8秒前
8秒前
科研通AI6.2应助janice116688采纳,获得20
9秒前
hey完成签到 ,获得积分10
10秒前
烦烦完成签到,获得积分10
10秒前
CATH完成签到 ,获得积分10
11秒前
14秒前
15秒前
century完成签到,获得积分10
15秒前
19秒前
ding应助LuoYixiang采纳,获得10
19秒前
19秒前
19秒前
丁3发布了新的文献求助10
22秒前
22秒前
CMC发布了新的文献求助10
23秒前
孤山完成签到 ,获得积分10
24秒前
读不懂文献的羊完成签到,获得积分10
26秒前
28秒前
六六完成签到,获得积分10
30秒前
山有木兮发布了新的文献求助10
33秒前
丁3完成签到,获得积分10
36秒前
朝槿完成签到 ,获得积分10
38秒前
壮观大炮完成签到,获得积分10
39秒前
科研通AI6.4应助小明采纳,获得10
40秒前
传奇3应助CMC采纳,获得10
44秒前
45秒前
49秒前
jinmai完成签到 ,获得积分10
50秒前
学习要认真喽完成签到 ,获得积分10
51秒前
今后应助碧蓝猕猴桃采纳,获得10
52秒前
阿源完成签到,获得积分20
52秒前
52秒前
53秒前
53秒前
ljm完成签到,获得积分10
54秒前
54秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
Burger's Medicinal Chemistry, Drug Discovery and Development, Volumes 1 - 8, 8 Volume Set, 8th Edition 1800
Cronologia da história de Macau 1600
Netter collection Volume 9 Part I upper digestive tract及Part III Liver Biliary Pancreas 3rd 2024 的超高清PDF,大小约几百兆,不是几十兆版本的 1050
Current concept for improving treatment of prostate cancer based on combination of LH-RH agonists with other agents 1000
Research Handbook on the Law of the Sea 1000
Contemporary Debates in Epistemology (3rd Edition) 1000
热门求助领域 (近24小时)
化学 材料科学 医学 生物 工程类 有机化学 纳米技术 计算机科学 化学工程 生物化学 物理 复合材料 内科学 催化作用 物理化学 光电子学 细胞生物学 基因 电极 遗传学
热门帖子
关注 科研通微信公众号,转发送积分 6165402
求助须知:如何正确求助?哪些是违规求助? 7992858
关于积分的说明 16620385
捐赠科研通 5272017
什么是DOI,文献DOI怎么找? 2812703
邀请新用户注册赠送积分活动 1792733
关于科研通互助平台的介绍 1658636